---
title: "Pliant Therapeutics, Inc. (PLRX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/PLRX.US.md"
symbol: "PLRX.US"
name: "Pliant Therapeutics, Inc."
industry: "Pharmaceuticals"
---

# Pliant Therapeutics, Inc. (PLRX.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | US Market |
| Website | [liantrx.com](https://liantrx.com) |

## Company Profile

Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company’s lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which h...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.43 | 85/257 | - | - | - |
| PB | 0.38 | 18/257 | 0.45 | 0.38 | 0.31 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-02T05:00:00.000Z

Total Analysts: **7**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 1 | 14% |
| Hold | 5 | 71% |
| Underweight | 1 | 14% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.24 |
| Highest Target | 4.00 |
| Lowest Target | 2.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/PLRX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/PLRX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/PLRX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.